Hôpital Edouard Herriot
Lyon, 69437, France
Location status: Recruiting
Location contact
Frederic MOLL, CRA
CONTACT
+33 472117504 ext. +33
Mathieu PIOCHE, MD
CONTACT
04.72.11.01.45 ext. +33
NCT Number: NCT07534800
Benign esophageal strictures are a common condition with multiple and varied causes. Esophageal strictures are manifested by the appearance of dysphagia, usually when the reduction in the esophageal lumen is greater than 50%. Malnutrition and aspiration pneumonia can also occur. Quality of life can thus be significantly impaired. To date, there are multiple techniques for treating strictures. Dilation (hydrostatic or bougie) is the historical first-line treatment. The effectiveness of the 2 historical dilation methods (balloon vs bougie) is comparable, with no difference in terms of adverse effects, with robust literature on the subject. There is a new device called the BougieCap™ (Ovesco Endoscopy AG, Tubingen, Germany). It is a short, tapered, conical-shaped transparent cap that attaches to the end of the endoscope. This cap allows the treatment of short strictures, with direct visualization during dilation.
The results of this research will be used to better evaluate the performance of the Bougie Cap™ in the endoscopic dilation of short benign esophageal strictures as well as its short-term effectiveness on dysphagia. Another advantage of this device, particularly compared to older techniques, is its ecological potential (lower packaging weight).
Interested in participating?
Request Info18 year and older
All sexes
Observational
Lyon, 69437, France
Location status: Recruiting
Frederic MOLL, CRA
CONTACT
+33 472117504 ext. +33
Mathieu PIOCHE, MD
CONTACT
04.72.11.01.45 ext. +33
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Patients managed with monthly BOUGIE CAP™ procedures for esophageal strictures will be evaluated during a 6-month follow-up
Patients managed with monthly BOUGIE CAP™ procedures for esophageal strictures during a 6-month follow-up will be assessed. The success of the endoscopic dilation sequence is defined by the technical ability to achieve dilation to a diameter of at least 14mm
Hospices Civils de Lyon
Other
Etude de Cohorte Sur l'Utilisation du Dispositif BOUGIE CAP™ Pour le Traitement Des sténoses œsophagiennes bénignes et Courtes
Acronym: BOUGIE CAP™
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07100379
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Boston, Massachusetts, United States
View Trial DetailsNCT05561114
Digestive System Diseases, Esophageal Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT06675825
Digestive System Diseases, Esophageal Dilation
Rome, Italy
View Trial DetailsNCT05431738
Digestive System Diseases, Digestive System Neoplasms
Paris, France
View Trial Details